about
Babesia divergens, a bovine blood parasite of veterinary and zoonotic importanceTranscriptomic Study on Ovine Immune Responses to Fasciola hepatica InfectionTegument Glycoproteins and Cathepsins of Newly Excysted Juvenile Fasciola hepatica Carry Mannosidic and Paucimannosidic N-glycansB-cell epitope mapping within the MA16 antigenic sequence found in Eimeria acervulina merozoites and sporozoites.Cathepsin L proteinases as vaccines against infection with Fasciola hepatica (liver fluke) in ruminants.Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages.Fasciola hepatica is associated with the failure to detect bovine tuberculosis in dairy cattle.Parasite vaccines--a reality?Angiostrongylus vasorum: a real heartbreaker.Age-stratified Bayesian analysis to estimate sensitivity and specificity of four diagnostic tests for detection of Cryptosporidium oocysts in neonatal calvesGastrointestinal nematode control practices on lowland sheep farms in Ireland with reference to selection for anthelmintic resistance.Cavernous sinus involvement by extramedullary plasmacytoma of the sphenoid sinus. An argument for the use of adjuvant chemotherapy.An Irish perspective on Cryptosporidium. Part 2.The worm turns: trematodes steering the course of co-infections.Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression.Fasciola hepatica vaccine: we may not be there yet but we're on the right roadFasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines.Comparison of diagnostic techniques for the detection of Cryptosporidium oocysts in animal samples.Helminths at mucosal barriers--interaction with the immune system.Determining the Prevalence and Seasonality of Fasciola hepatica in Pasture-based Dairy herds in Ireland using a Bulk Tank Milk ELISA.Clinical research: developing an appropriate career structure.Rumen fluke in Irish sheep: prevalence, risk factors and molecular identification of two paramphistome species.Possible mechanisms underlying age-related resistance to bovine babesiosis.Tissue migration by parasitic helminths - an immunoevasive strategy?Canine pododermatitis and idiopathic disease.Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes.Coordinating innate and adaptive immunity in Fasciola hepatica infection: implications for control.An Irish perspective on Cryptosporidium. Part 1.Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development.Bovine paramphistomes in Ireland.Editorial-One Health Special Issue-Parasite Immunology.Standardisation of egg-viability assays for Fasciola hepatica and Calicophoron daubneyi: A tool for evaluating new technologies of parasite control.The immunoregulatory effects of co-infection with Fasciola hepatica: From bovine tuberculosis to Johne's disease.Early and late peritoneal and hepatic changes in goats immunized with recombinant cathepsin L1 and infected with Fasciola hepatica.Panmictic structure of the Cryptosporidium parvum population in Irish calves: influence of prevalence and host movement.Interaction of Eimeria tenella with intestinal mucin in vitro.Migration of Fasciola hepatica newly excysted juveniles is inhibited by high-mannose and oligomannose-type N-glycan-binding lectins.Network Analysis of the Systemic Response to Fasciola hepatica Infection in Sheep Reveals Changes in Fibrosis, Apoptosis, Toll-Like Receptors 3/4, and B Cell Function.Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cellsHigh-resolution mapping of B-cell epitopes within an antigenic sequence from Eimeria tenella.
P50
Q24681513-337DB03F-9679-42DC-A8EC-C33C44DEBC71Q27303435-B79CD97E-4022-477C-A296-43274E15C8A7Q28551767-E1FFEF9E-9C95-42C5-BED3-22BAD6CF0941Q30426376-9428E986-6C1B-46C6-80D3-3A361B3A8279Q31917950-CD0032F8-3F18-4354-AEEC-8A764FE8521AQ33556819-D63353B5-FBE0-4118-BF3C-357D349956A6Q34276631-B9B7B946-3189-4D1F-B88A-11A2FE07F4D4Q34343077-22EE9972-48FF-4BF2-99B4-EB3143C74CB8Q34387009-7CDFEF25-EA1B-453E-AF04-D69B80D878B2Q34487650-3EE3A823-A522-4286-A452-CBA4F808FE30Q35008160-6EDA8BCD-5810-41F4-874E-CC5CA8799856Q35025693-B4B02A84-3932-4702-BBA0-EED96955EAF8Q35041977-2EE3E93F-0039-46D7-B1FA-AF3AB3B37E20Q35103010-5D4C7104-D703-4A8A-B32E-0556A7A76193Q35143303-5D5300D8-3C85-4414-927A-1D6E474A3E65Q35195502-670BFCA0-10A0-45F1-9F6B-63F1662CBB00Q35295108-B33992A2-5F3E-4658-A810-B00A34A7C570Q35523897-249D2E77-CA92-402E-AC9F-F4E979388F09Q35737879-B4CCA816-CED6-4D7F-A425-020993E8A882Q35830674-11027882-6D3A-444C-ACDC-936FA80D8E49Q35854321-46DBECE5-C40A-42F3-85C6-EDA8959982E2Q36080903-E880D1BC-EFE2-4EA1-8571-9E72257D0F6CQ36135447-83FED6F4-75ED-4199-B8BB-5E3C1E04E4E4Q36142595-0C2F25AF-673A-496C-8776-262938BBB91DQ36962633-EB95832C-EEC4-4503-BFA1-EC050D8DE94FQ37523679-E663037E-5825-465B-8E36-EBE3ACF7DA5CQ37706716-08C38E96-F301-4B99-BDA8-E2C11E3EA6C8Q37919599-C524E536-7014-4F40-819E-5DFEC29855D1Q38102390-762A91A5-1F40-4920-9608-16207763A199Q38218371-0701FFAC-4F04-4831-883F-F45CD4CA61ABQ38930510-5802AEA7-926F-46EC-A08C-9DDE02BD899AQ39019182-BA102AE7-2A1F-4FB5-B075-0AF71855289AQ39243377-1BF1FC25-60DC-4001-8758-FC223FF3498BQ39533706-AFAF08B6-EDE9-4C58-8106-7BE0CB7663D4Q39763126-809911D6-7A06-4D78-AD66-6FA8DD3BA907Q40108044-30E19064-B6F0-454E-8D87-8EEB878F0855Q40141979-B8794108-8E7C-4B44-8211-B25EB8AB1C17Q40219501-3A3CCCA6-9ECA-40FE-9444-731FEC1ABB0BQ40337680-3C1615C5-D408-46C0-9D51-A7BDB73DC07CQ40375518-E4ACBA88-F035-46FE-9B4C-FEA76F29BC58
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Grace Mulcahy
@ast
Grace Mulcahy
@en
Grace Mulcahy
@es
Grace Mulcahy
@nl
Grace Mulcahy
@sl
type
label
Grace Mulcahy
@ast
Grace Mulcahy
@en
Grace Mulcahy
@es
Grace Mulcahy
@nl
Grace Mulcahy
@sl
prefLabel
Grace Mulcahy
@ast
Grace Mulcahy
@en
Grace Mulcahy
@es
Grace Mulcahy
@nl
Grace Mulcahy
@sl
P106
P21
P31
P496
0000-0001-5921-3834